{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:20:01Z","timestamp":1770898801994,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,8,27]],"date-time":"2016-08-27T00:00:00Z","timestamp":1472256000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s40266-016-0393-y","type":"journal-article","created":{"date-parts":[[2016,8,27]],"date-time":"2016-08-27T01:34:12Z","timestamp":1472261652000},"page":"675-683","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Treatment with Optimal Dose Angiotensin-Converting Enzyme Inhibitors\/Angiotensin Receptor Blockers Has a Positive Effect on Long-Term Survival in Older Individuals (Aged >70\u00a0Years) and Octogenarians with Systolic Heart Failure"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5792-6723","authenticated-orcid":false,"given":"Luis","family":"Sargento","sequence":"first","affiliation":[]},{"given":"Andre Vicente","family":"Sim\u00f5es","sequence":"additional","affiliation":[]},{"given":"Susana","family":"Longo","sequence":"additional","affiliation":[]},{"given":"Nuno","family":"Lousada","sequence":"additional","affiliation":[]},{"given":"Roberto Palma","family":"dos Reis","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,8,27]]},"reference":[{"key":"393_CR1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ahj.2009.04.011","volume":"158","author":"D Miani","year":"2009","unstructured":"Miani D, Fresco C, Lucci D, et al. Italian Survey on Acute Heart Failure Investigators. Clinical characteristics, management, and prognosis of octogenarians with acute heart failure admitted to cardiology wards: results from the Italian Survey on Acute Heart Failure. Am Heart J. 2009;158:126\u201332.","journal-title":"Am Heart J"},{"key":"393_CR2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1067\/mhj.2002.120773","volume":"143","author":"EP Havranek","year":"2002","unstructured":"Havranek EP, Masoudi FA, Westfall KA, et al. Spectrum of heart failure in older patients: results from the National Heart Failure Project. Am Heart J. 2002;143:412\u20137.","journal-title":"Am Heart J"},{"key":"393_CR3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","volume":"355","author":"TE Owan","year":"2006","unstructured":"Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. New Engl J Med. 2006;355:251\u20139.","journal-title":"New Engl J Med."},{"key":"393_CR4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1053\/euhj.1998.1280","volume":"20","author":"MR Cowie","year":"1999","unstructured":"Cowie MR, Wood DA, Coats AJ, et al. Incidence and aetiology of heart failure; a population-based study. Eur Heart J. 1999;20:421\u20138.","journal-title":"Eur Heart J"},{"key":"393_CR5","first-page":"165","volume":"12","author":"D Zachariah","year":"2015","unstructured":"Zachariah D, Taylor J, Rowell N, et al. Drug therapy for heart failure in older patients: what do they want? J Geriatr Cardiol. 2015;12:165\u201373.","journal-title":"J Geriatr Cardiol."},{"key":"393_CR6","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs033","volume":"14","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD, ESC Committee for Practice Guidelines, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803\u201369.","journal-title":"Eur J Heart Fail"},{"key":"393_CR7","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ijcard.2015.03.428","volume":"187","author":"SB Barywani","year":"2015","unstructured":"Barywani SB, Ergatoudes C, Schaufelberger M, et al. Does the target dose of neurohormonal blockade matter for outcome in systolic heart failure in octogenarians? Int J Cardiol. 2015;187:666\u201372.","journal-title":"Int J Cardiol"},{"key":"393_CR8","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/CIRCHEARTFAILURE.109.912683","volume":"3","author":"JT Heywood","year":"2010","unstructured":"Heywood JT, Fonarow GC, Yancy CW, et al. Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF. Circ Heart Fail. 2010;3:596\u2013605.","journal-title":"Circ Heart Fail."},{"key":"393_CR9","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.amjcard.2009.12.016","volume":"105","author":"JT Heywood","year":"2010","unstructured":"Heywood JT, Fonarow GC, Yancy CW, et al. Influence of renal function on the use of guideline-recommended therapies for patients with heart failure. Am J Cardiol. 2010;105:1140\u20136.","journal-title":"Am J Cardiol"},{"key":"393_CR10","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/eurjhf\/hfq154","volume":"12","author":"AP Maggioni","year":"2010","unstructured":"Maggioni AP, Dahlstr\u00f6m U, Filippatos G, et al. The heart failure pilot survey (ESCHF Pilot). Eur J Heart Fail. 2010;12:1076\u201384.","journal-title":"Eur J Heart Fail"},{"key":"393_CR11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1751-7133.2011.00250.x","volume":"18","author":"M Gheorghiade","year":"2012","unstructured":"Gheorghiade M, Albert NM, Curtis AB, et al. Medication dosing in outpatients with heart failure after implementation of a practice-based performance improvement intervention: findings from IMPROVE HF. Congest Heart Fail. 2012;18:9\u201317.","journal-title":"Congest Heart Fail."},{"key":"393_CR12","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","volume":"106","author":"M Packer","year":"2002","unstructured":"Packer M, Fowler MB, Roecker EB, et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation. 2002;106:2194\u20139.","journal-title":"Circulation"},{"key":"393_CR13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","volume":"26","author":"MD Flather","year":"2005","unstructured":"Flather MD, Shibata MC, Coats AJ, et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J. 2005;26:215\u201325.","journal-title":"Eur Heart J"},{"key":"393_CR14","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.CIR.94.11.2807","volume":"94","author":"MR Bristow","year":"1996","unstructured":"Bristow MR, Gilbert EM, Abraham WT, et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation. 1996;94:2807\u201316.","journal-title":"Circulation"},{"key":"393_CR15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cardfail.2003.10.012","volume":"10","author":"M Svensson","year":"2004","unstructured":"Svensson M, Gustafsson F, Galatius S, et al. How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure? J Card Fail. 2004;10:297\u2013303.","journal-title":"J Card Fail."},{"key":"393_CR16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/eurjhf\/hfs151","volume":"15","author":"FH Verbrugge","year":"2013","unstructured":"Verbrugge FH, Dupont M, De Vusser P, et al. Response to cardiac resynchronization therapy in elderly patients (\u226570\u00a0years) and octogenarians. Eur J Heart Fail. 2013;15:203\u201310.","journal-title":"Eur J Heart Fail"},{"key":"393_CR17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/eurheartj\/ehp024","volume":"30","author":"M Metra","year":"2009","unstructured":"Metra M, Dei Cas L, Massie BM. Treatment of heart failure in the elderly: never say it\u2019s too late. Eur Heart J. 2009;30:391\u20133.","journal-title":"Eur Heart J."},{"key":"393_CR18","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","volume":"100","author":"M Packer","year":"1999","unstructured":"Packer M, Poole-Wilson PA, Armstrong PW, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation. 1999;100:2312\u20138.","journal-title":"Circulation"},{"key":"393_CR19","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/S0140-6736(09)61913-9","volume":"374","author":"MA Konstam","year":"2009","unstructured":"Konstam MA, Neaton JD, Dickstein K, et al. Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomized, double-blind trial. Lancet. 2009;374:1840\u20138.","journal-title":"Lancet"},{"key":"393_CR20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/ehjcvp\/pvv016","volume":"1","author":"CT Witt","year":"2015","unstructured":"Witt CT, Kronborg MB, Nohr EA, et al. Optimization of heart failure medication after cardiac resynchronization therapy and the impact on long-term survival. Eur Heart J Cardiovasc Pharmacother. 2015;1:182\u20138.","journal-title":"Eur Heart J Cardiovasc Pharmacother."},{"key":"393_CR21","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.amjcard.2007.06.019","volume":"100","author":"BA Steinberg","year":"2007","unstructured":"Steinberg BA, Cannon CP, Hernandez AF, et al. Medical therapies and invasive treatments for coronary artery disease by body mass: the \u201cobesity paradox\u201d in the Get With The Guidelines database. Am J Cardiol. 2007;100:1331\u20135.","journal-title":"Am J Cardiol"},{"key":"393_CR22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/eurjhf\/hfs060","volume":"14","author":"D Cullington","year":"2012","unstructured":"Cullington D, Goode KM, Clark AL, Cleland JG. Heart rate achieved or betablocker dose in patients with chronic heart failure: which is the better target? Eur J Heart Fail. 2012;14:737\u201347.","journal-title":"Eur J Heart Fail"},{"key":"393_CR23","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0002-8703(03)00189-3","volume":"146","author":"FA Masoudi","year":"2003","unstructured":"Masoudi FA, Havranek EP, Wolfe P, et al. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J. 2003;146:250\u20137.","journal-title":"Am Heart J"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-016-0393-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-016-0393-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-016-0393-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:30:05Z","timestamp":1498325405000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-016-0393-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,27]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["393"],"URL":"https:\/\/doi.org\/10.1007\/s40266-016-0393-y","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,27]]}}}